https://geneonline.news/tirzepatide-reduced-the-risk-of-developing-type-2-diabetes-by-94-in-adults-with-pre-diabetes-and-obesity-or-overweight/2024-09-05T16:39:50.000Zweekly0.8 https://geneonline.news/bora-completes-acquisition-of-us-sterile-fill-finish-facility-from-emergent/2024-09-05T16:40:02.000Zweekly0.8 https://geneonline.news/astrazeneca-daiichi-sankyo-enhertu-breakthrough-therapy-designation-ema-validation/2024-09-05T16:40:04.000Zweekly0.8 https://geneonline.news/gsk-b7-h3-adc-us-fda-breakthrough-therapy-designation/2024-09-05T16:39:26.000Zweekly0.8 https://geneonline.news/2024-h2-obesity-clinical-trials/2024-09-12T17:53:19.000Zweekly0.8 https://geneonline.news/biotech-financing-darkest-before-the-dawn/2024-09-05T16:40:13.000Zweekly0.8 https://geneonline.news/2024-q2-financial-report-az-gsk/2024-09-09T14:57:13.000Zweekly0.8 https://geneonline.news/fda-roundup-august-16-2024/2024-09-05T16:40:15.000Zweekly0.8 https://geneonline.news/stli-2024-webinar2-nucleic-acid-drugs/2026-01-26T14:05:44.000Zweekly0.8 https://geneonline.news/taiwan-advance-bio-pharmaceutical-spinal-cord-injury/2024-08-16T15:21:40.000Zweekly0.8 https://geneonline.news/incyte-and-syndax-announce-u-s-fda-approval-of-niktimvo-axatilimab-csfr-for-the-treatment-of-chronic-graft-versus-host-disease/2024-08-28T11:22:28.000Zweekly0.8 https://geneonline.news/u-s-government-announces-final-prices-for-first-10-medicare-part-d-drugs-marking-completion-of-historic-drug-price-negotiations/2024-09-12T17:53:17.000Zweekly0.8 https://geneonline.news/fda-rejects-ecstasy-as-a-therapeutic-drug-whats-next-for-psychedelic-therapy/2024-08-28T11:21:58.000Zweekly0.8 https://geneonline.news/astrazenecas-two-major-therapies-approved-in-the-us-and-europe-offering-new-opportunities-for-endometrial-cancer-and-small-cell-lung-cancer-treatments/2024-08-28T11:22:03.000Zweekly0.8 https://geneonline.news/gileads-livdelzi-seladelpar-granted-accelerated-approval-for-primary-biliary-cholangitis-by-u-s-fda/2024-08-28T11:22:08.000Zweekly0.8 https://geneonline.news/moderna-and-coursera-launch-free-course-on-mrna-technology/2024-08-15T14:09:01.000Zweekly0.8 https://geneonline.news/alzheimers-disease-cellular-resilience-wtchen-interview/2026-01-26T14:06:10.000Zweekly0.8 https://geneonline.news/illumina-announces-strategy-to-accelerate-value-creation/2024-08-28T11:22:15.000Zweekly0.8 https://geneonline.news/leqembi-lecanemab-approved-for-the-treatment-of-alzheimers-disease-in-the-united-arab-emirates/2024-08-28T11:22:21.000Zweekly0.8 https://geneonline.news/neuronal-substance-p-drives-metastasis-through-an-extracellular-rnatlr7-axis/2024-08-28T11:21:34.000Zweekly0.8 https://geneonline.news/enhertu-approved-in-china-for-patients-with-previously-treated-her2-positive-advanced-or-metastatic-gastric-cancer/2024-08-22T11:27:34.000Zweekly0.8 https://geneonline.news/lilly-opens-state-of-the-art-research-and-development-center-in-the-boston-seaport/2024-08-22T11:27:40.000Zweekly0.8 https://geneonline.news/formosa-pharmaceuticals-listed-on-the-taiwan-stock-exchange/2024-08-22T11:27:42.000Zweekly0.8 https://geneonline.news/oneness-biotech-fespixon-indonesian-approval/2024-08-22T11:27:44.000Zweekly0.8 https://geneonline.news/blood-test-uses-protein-clock-to-predict-risk-of-alzheimers-and-other-diseases/2024-08-19T14:34:13.000Zweekly0.8 https://geneonline.news/merck-to-acquire-investigational-b-cell-depletion-therapy-cn201-from-curon-biopharmaceutical/2024-08-19T14:34:03.000Zweekly0.8 https://geneonline.news/fda-approves-first-nasal-spray-for-treatment-of-anaphylaxis/2024-08-21T16:05:04.000Zweekly0.8 https://geneonline.news/2024-q2-financial-report-bayer-gilead-illumina-beigene/2024-08-19T16:38:25.000Zweekly0.8 https://geneonline.news/serviers-1-8-billion-acquisition-pays-off-fda-approves-first-in-class-treatment-for-two-types-of-rare-brain-cancer/2024-08-09T18:11:14.000Zweekly0.8 https://geneonline.news/novartis-receives-fda-accelerated-approval-for-fabhalta-iptacopan-the-first-and-only-complement-inhibitor-for-the-reduction-of-proteinuria-in-primary-iga-nephropathy-igan/2024-08-09T17:20:35.000Zweekly0.8 https://geneonline.news/2024-q2-financial-report-elililly-novonordisk-amgen-biontech-zoetis/2024-08-19T14:33:33.000Zweekly0.8 https://geneonline.news/2024-us-top-10-biocluster/2024-08-19T14:33:18.000Zweekly0.8 https://geneonline.news/delivering-affordable-biologic-medicines-worldwide-an-interview-with-tanvex-chairman-and-ceo-henry-chen/2024-08-19T14:29:48.000Zweekly0.8 https://geneonline.news/2024-q2-financial-report-moderna_teva_abbott_biogen_thermofisher/2024-08-19T14:30:41.000Zweekly0.8 https://geneonline.news/2024-q2-financial-report-pfizer-vertex-regeneron-bms-merck/2024-08-19T14:30:46.000Zweekly0.8 https://geneonline.news/healthy-ageing-tech-show-2024-closing/2024-08-19T14:31:32.000Zweekly0.8 https://geneonline.news/2024-q2-financial-report-jj-abbvie-msd-roche-novartis/2024-08-19T14:31:16.000Zweekly0.8 https://geneonline.news/nycu-healthy-ageing-tech-forum/2024-08-14T14:17:45.000Zweekly0.8 https://geneonline.news/healthy-ageing-tech-show-2024-opening/2024-08-14T14:17:41.000Zweekly0.8 https://geneonline.news/bio-asia-taiwan-2024-review/2024-08-14T14:17:36.000Zweekly0.8 https://geneonline.news/bio-asia-taiwan-2024-digital-health/2024-08-14T14:17:31.000Zweekly0.8 https://geneonline.news/bio-asia-taiwan-2024-biosimilar-conference/2024-08-14T14:14:24.000Zweekly0.8 https://geneonline.news/bio-asia-taiwan-2024-regional-collaboration-forum/2024-08-14T14:14:17.000Zweekly0.8 https://geneonline.news/bio-asia-taiwan-2024-investment-summit/2024-08-14T14:13:48.000Zweekly0.8 https://geneonline.news/session-12-advances-in-genetics-and-precision-medicine-in-human-diseases/2024-08-14T14:08:26.000Zweekly0.8 https://geneonline.news/session-11-ai-revolutionizing-pharma-transformative-approaches-in-drug-discovery-and-clinical-trials/2024-08-14T13:44:10.000Zweekly0.8 https://geneonline.news/2024-bio-asia-taiwan-exhibition-opening-ceremony/2024-08-14T13:44:15.000Zweekly0.8 https://geneonline.news/mrna-gene-therapy-cmc-translational-medicine/2024-08-14T13:44:26.000Zweekly0.8 https://geneonline.news/gilead-elton-john-aids-foundation-radian-collaboration/2024-08-14T13:44:38.000Zweekly0.8 https://geneonline.news/2024-bio-asia-taiwan-opening-and-lectures/2024-08-14T13:44:48.000Zweekly0.8 https://geneonline.news/european-commission-pharmaceutical-package/2024-08-07T16:34:52.000Zweekly0.8 https://geneonline.news/2-diabetes-mellitus-eye-disease-treatments-roche-macular-edema-and-retinopathy-clinical-trial-showed-positive-data/2024-08-07T16:35:02.000Zweekly0.8 https://geneonline.news/2024-bio-asia-taiwan-canada-pavilion/2024-08-07T16:35:18.000Zweekly0.8 https://geneonline.news/fda-2023-dec-potency-assurance-for-cellular-and-gene-therapy-products-draft-guidance-for-industry/2024-07-18T12:02:24.000Zweekly0.8 https://geneonline.news/astrazeneca-acquire-amolyt-pharma-to-include-hypoparathyroidism-drug/2024-08-07T16:35:28.000Zweekly0.8 https://geneonline.news/eisai-biogen-alzheimer-durg-approve-in-hong-kong-and-israel/2024-08-07T16:35:39.000Zweekly0.8 https://geneonline.news/bayer-askbio-parkinson-aav2-gdnf-gene-therapy/2024-08-07T16:36:00.000Zweekly0.8 https://geneonline.news/115m-series-a-boosts-myricx-bios-adc-development-with-lilly-and-novo-support/2024-08-07T16:36:05.000Zweekly0.8 https://geneonline.news/eli-lilly-acquire-morphic-for-ibd-therapy/2024-08-07T16:36:12.000Zweekly0.8 https://geneonline.news/2024-taiwan-bio-awards-2/2024-08-07T16:36:22.000Zweekly0.8 https://geneonline.news/stli-2024-webinar1-regenerative-medicine/2026-01-26T13:58:21.000Zweekly0.8 https://geneonline.news/healthy-ageing-tech-show-preview/2024-08-14T13:45:11.000Zweekly0.8 https://geneonline.news/roche-accu-chek-smartguide-diabetes-certification/2024-08-07T16:36:42.000Zweekly0.8 https://geneonline.news/sanofi-regeneron_copd-ema-approval/2024-08-07T16:36:46.000Zweekly0.8 https://geneonline.news/alzheimers-innovative-drug-development-2024/2024-08-07T16:36:52.000Zweekly0.8 https://geneonline.news/eli-lilly-openai-alzheimer-drug-approval/2024-08-07T16:36:57.000Zweekly0.8 https://geneonline.news/ginkgo-job-cuts-expected-to-affect-at-least-35-of-workforce-eliminating-up-to-400-jobs/2024-07-22T11:48:50.000Zweekly0.8 https://geneonline.news/tanvex-biopharma-tx01-fda-bla/2024-07-22T11:48:43.000Zweekly0.8 https://geneonline.news/regeneron-progress-on-dupixent-odronextamab/2024-07-22T11:48:40.000Zweekly0.8 https://geneonline.news/astrazeneca-mibc-imfinzi-niagara-nsclc-adjuvant-br31/2024-07-22T11:48:37.000Zweekly0.8 https://geneonline.news/takeda-mcrc-cmv-itp/2024-07-22T11:48:30.000Zweekly0.8 https://geneonline.news/2024-bio-asia-taiwan-overview/2024-08-07T16:37:02.000Zweekly0.8 https://geneonline.news/gilead-lenacapavir-cisgender-women-efficacy/2024-07-22T11:24:31.000Zweekly0.8 https://geneonline.news/sartorius-sterile-filtration-technology-and-integrity-testing-seminar/2024-07-22T11:44:39.000Zweekly0.8 https://geneonline.news/illumina-ai-precision-medicine-drug-discovery/2026-01-26T13:55:51.000Zweekly0.8 https://geneonline.news/bms-krazati-nivolumab-regulatory-progress/2024-07-22T11:44:40.000Zweekly0.8 https://geneonline.news/roche-ventana-kappa-and-lambda-dual-ish-mrna-probe-cocktail-assay/2024-07-22T11:47:30.000Zweekly0.8 https://geneonline.news/2024-medical-taiwan/2024-07-15T11:14:49.000Zweekly0.8 https://geneonline.news/2024_tang_prize_glp-1/2024-07-31T11:49:25.000Zweekly0.8 https://geneonline.news/10_drug_shortage/2024-07-15T11:15:12.000Zweekly0.8 https://geneonline.news/akkermansia-muciniphila-in-obesity-and-diabetes/2024-07-01T10:39:55.000Zweekly0.8 https://geneonline.news/rediscover-microorganisms-clinics-open-ceremony/2024-07-30T17:54:35.000Zweekly0.8 https://geneonline.news/ochrebio-gsk-licensing-liver-disease/2024-07-01T10:40:17.000Zweekly0.8 https://geneonline.news/huntington-disease-genetic-carrier-risk/2024-07-01T10:42:01.000Zweekly0.8 https://geneonline.news/precisemab-biotech-bio-international-convention/2024-06-14T11:08:07.000Zweekly0.8 https://geneonline.news/ab-digihealth-bio-2024-ai-icone/2024-06-14T11:15:55.000Zweekly0.8 https://geneonline.news/moleculex-in-bio-2024/2024-06-14T10:48:58.000Zweekly0.8 https://geneonline.news/2024-latest-10-alzheimer-disease-drug-and-therapy/2024-07-03T11:00:29.000Zweekly0.8 https://geneonline.news/asco-2024-durvalumab-following-chemoradiotherapy-improved-survival-in-patients-with-limited-stage-small-cell-lung-cancer/2024-06-11T15:46:00.000Zweekly0.8 https://geneonline.news/asco-2024-osimertinib-poised-to-change-standard-of-care-treatment-for-patients-with-locally-advanced-egfr-mutated-nsclc/2024-06-11T15:05:02.000Zweekly0.8 https://geneonline.news/asco-2024-dual-immunotherapy-treatment-before-surgery-rather-than-after-improves-outcomes-in-melanoma-patients/2024-06-11T14:41:42.000Zweekly0.8 https://geneonline.news/asco-2024-lymphadenectomy-may-not-be-needed-for-patients-with-advanced-ovarian-cancer/2024-06-11T14:41:39.000Zweekly0.8 https://geneonline.news/asco-2024-american-society-of-clinical-oncology-and-american-cancer-society-unite-to-create-one-of-the-largest-and-most-comprehensive-online-sources-of-credible-cancer-information/2024-06-11T14:41:37.000Zweekly0.8 https://geneonline.news/asco-2024-novel-therapy-combination-more-effective-at-treating-hodgkin-lymphoma-than-established-treatment/2024-07-01T10:42:30.000Zweekly0.8 https://geneonline.news/asco-2024-lorlatinib-longest-progression-free-survival-ever-reported-in-advanced-nsclc/2024-07-01T10:44:04.000Zweekly0.8 https://geneonline.news/asco-2024-asciminib-may-be-safer-more-effective-treatment-option-for-patients-with-newly-diagnosed-chronic-myeloid-leukemia/2024-07-01T10:51:58.000Zweekly0.8 https://geneonline.news/tanvex-cdmo-bio-us-2024/2024-06-18T10:51:13.000Zweekly0.8 https://geneonline.news/everfront-biotech-bio-us-2024-brain-tumor-als-spleencancer/2024-06-18T10:49:31.000Zweekly0.8 https://geneonline.news/bio2024-simpson-biotech-presents-proprietary-yeast-expression-platform-for-recombinant-protein-oem-odm/2024-06-18T10:51:23.000Zweekly0.8 https://geneonline.news/bio-2024-taiwan-pavilion-cdmo-zone/2024-06-24T20:14:57.000Zweekly0.8